Biochemical properties and regulation of cathepsin K activity

被引:139
作者
Lecaille, Fabien [1 ]
Broemme, Dieter [2 ,3 ]
Lalmanach, Gilles [1 ]
机构
[1] Univ Tours, Fac Med, Equipe Proteases & Pathol Pulm, INSERM,U618, F-37032 Tours, France
[2] Univ British Columbia, Fac Dent, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada
基金
美国国家卫生研究院;
关键词
cystatin; cysteine cathepsin; cysteine protease; kininogen; stefin; substrate specificity; osteoporosis;
D O I
10.1016/j.biochi.2007.08.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cysteine cathepsins (11 in humans) are mostly located in the acidic compartments of cells. They have been known for decades to be involved in intracellular protein degradation as housekeeping proteases. However, the discovery of new cathepsins, including cathepsins K, V and F, has provided strong evidence that they also participate in specific biological events. This review focuses on the current knowledge of cathepsin K, the major bone cysteine protease, which is a drug target of clinical interest. Nevertheless, we will not discuss recent developments in cathepsin K inhibitor design since they have been extensively detailed elsewhere. We will cover features of cathepsin K structure, cellular and tissue distribution, substrate specificity, and regulation (pH, propeptide, glycosaminoglycans, oxidants), and its putative roles in physiological or pathophysiological processes. Finally, we will review the kinetic data of its inhibition by natural endogenous inhibitors (stefin B, cystatin C, H- and L-kininogens). (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:208 / 226
页数:19
相关论文
共 280 条
[1]   HUMAN CYSTATIN-C - ROLE OF THE N-TERMINAL SEGMENT IN THE INHIBITION OF HUMAN CYSTEINE PROTEINASES AND IN ITS INACTIVATION BY LEUKOCYTE ELASTASE [J].
ABRAHAMSON, M ;
MASON, RW ;
HANSSON, H ;
BUTTLE, DJ ;
GRUBB, A ;
OHLSSON, K .
BIOCHEMICAL JOURNAL, 1991, 273 :621-626
[2]   Cystatins [J].
Abrahamson, M ;
Alvarez-Fernandez, M ;
Nathanson, CM .
PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES, 2003, 70 :179-199
[3]  
ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685
[4]  
ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282
[5]   Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors? [J].
Adkison, KK ;
Barrett, DG ;
Deaton, DN ;
Gampe, RT ;
Hassell, AM ;
Long, ST ;
McFadyen, RB ;
Miller, AB ;
Miller, LR ;
Payne, JA ;
Shewchuk, LM ;
Wells-Knecht, KJ ;
Willard, DH ;
Wright, LL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) :978-983
[6]  
AHLBERG J, 1985, J BIOL CHEM, V260, P5847
[7]  
Aibe K, 1996, BIOL PHARM BULL, V19, P1026
[8]   Cathepsin B activity regulation - Heparin-like glycosaminoglycans protect human cathepsin B from alkaline pH-induced inactivation [J].
Almeida, PC ;
Nantes, IL ;
Chagas, JR ;
Rizzi, CCA ;
Faljoni-Alario, A ;
Carmona, E ;
Juliano, L ;
Nader, HB ;
Tersariol, ILS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :944-951
[9]   Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia [J].
Altiok, O ;
Yasumatsu, R ;
Bingol-Karakoc, G ;
Riese, RJ ;
Stahlman, MT ;
Dwyer, W ;
Pierce, RA ;
Bromme, D ;
Weber, E ;
Cataltepe, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (03) :318-326
[10]   Novel purine nitrile derived inhibitors of the cysteine protease cathepsin K [J].
Altmann, E ;
Cowan-Jacob, SW ;
Missbach, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) :5833-5836